WTFG
AMPE

Wells Trecaso Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Wells Trecaso Financial Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33
Closed -$5K – 93
2022
Q1 		$5K Hold
33
– – ﹤0.01% 89
2021
Q4 		$6K Hold
33
– – ﹤0.01% 92
2021
Q3 		$17K Hold
33
– – 0.01% 87
2021
Q2 		$17K Buy
+33
New +$17.7K 0.01% 85

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Trecaso Financial Group's AMPE Position: Q2 2022 in Review

Wells Trecaso Financial Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 33 shares — an estimated $5K sold.

Wells Trecaso Financial Group first reported a position in AMPE in Q2 2021 and held it in 4 quarters. The position peaked at $17K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • Wells Trecaso Financial Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • Wells Trecaso Financial Group sold 33 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $5K.
  • Wells Trecaso Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 4 quarters.
  • Wells Trecaso Financial Group's Ampio Pharmaceuticals Inc. position peaked at $17K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Wells Trecaso Financial Group's 13F filing for Q2 2022, filed 27 Jul 2022.